Literature DB >> 2786996

Interleukins 4 and 5 control expression of IL-2 receptor on murine B cells through independent induction of its two chains.

M S Loughnan1, G J Nossal.   

Abstract

Resting B cells express few, if any, receptors for interleukin-2 (IL-2), whereas activated B cells can express receptors for and respond to IL-2. IL-2 receptors can exist on the cell surface in three different forms; the complete high-affinity receptor, a heterodimer consisting of a chain of relative molecular mass (Mr) 70-75,000 (70-75K) and a chain of Mr 55K; the 70-75K chain alone, with intermediate affinity for IL-2; or the 55K chain alone, with low affinity for IL-2. We have previously reported that IL-5-stimulated B cells are induced to express the 55K chain. We report here evidence for the differential regulation of the expression of the two chains, namely that IL-4 and IL-5 can independently induce expression of the 70-75K and 55K chains respectively on murine B cells. As expected, cells stimulated to express the 55K chain alone are unresponsive to IL-2, whereas cells stimulated to express either the 70-75K chain or the 70-75/55K heterodimer respond to IL-2, at a high and low ligand concentration respectively, with a marked increase in proliferation. This orchestration of receptor expression and factor responsiveness may represent a novel activation pathway for B cells, where the two chains of a compound receptor are shown to be independently regulated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786996     DOI: 10.1038/340076a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  10 in total

Review 1.  Molecular mechanism and function of CD40/CD40L engagement in the immune system.

Authors:  Raul Elgueta; Micah J Benson; Victor C de Vries; Anna Wasiuk; Yanxia Guo; Randolph J Noelle
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

2.  Longitudinal survey in an endemic region of plasma soluble interleukin-2 receptor and antibody levels in Plasmodium falciparum malaria.

Authors:  B F Chumpitazi; F Peyron; J Simon; C Boudin; I Sheick-Zakiuddin; S Picot; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

Review 3.  Self-nonself discrimination and tolerance in T and B lymphocytes.

Authors:  J F Miller
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 4.  Cellular signalling mechanisms in B lymphocytes.

Authors:  W Cushley; M M Harnett
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

5.  Expression of IL-2 receptor p55 and p75 chains by human B lymphocytes: effects of activation and differentiation.

Authors:  H Zola; H Weedon; G R Thompson; M C Fung; E Ingley; A J Hapel
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

6.  Interleukin-4 regulates the interleukin-2 receptors on human peripheral blood B lymphocytes.

Authors:  K Tomizawa; A Ishizaka; K Kojima; M Nakanishi; Y Sakiyama; S Matsumoto
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

7.  The acquisition of cytokine responsiveness by murine B cells: a role for antigen and IL-5 in the induction of IL-2 receptors.

Authors:  J Poudrier; T Owens
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

8.  Flow cytometric studies of IL-4-stimulated expression of the CD25 antigen by quiescent human B lymphocyte subpopulations.

Authors:  R D Butcher; W Cushley
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

9.  Role and regulation of interleukin (IL)-2 receptor alpha and beta chains in IL-2-driven B-cell growth.

Authors:  K Nakanishi; S Hirose; T Yoshimoto; H Ishizashi; K Hiroishi; T Tanaka; T Kono; M Miyasaka; T Taniguchi; K Higashino
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

10.  Cytokine production by peripheral blood mononuclear cells in IgA nephropathy.

Authors:  K N Lai; J C Leung; P K Li; S F Lui
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.